These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 14970)

  • 1. Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism.
    Hayashi M; Floyd JC; Pek S; Fajans SS
    J Clin Endocrinol Metab; 1977 Apr; 44(4):681-94. PubMed ID: 14970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersecretion of insulin, glucagon and gastrin in a kindred with multiple adenomatosis.
    Vance JE; Kitabchi AE; Buchanan KD; Stoli RW; Hollander D; Wood FC
    Diabetes; 1968; 17():299. PubMed ID: 4385088
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum and pancreatic immunoreactive insulin (IRI) and proinsulin-like component (PLC), serum IRI and PLC response to different stimuli in normal subjects and organic hyperinsulinism.
    Rastogi GK; Sialy R; Sinha MK; Dash R; Chopra JS; Kataria RN
    Acta Diabetol Lat; 1975; 12(5-6):309-23. PubMed ID: 181932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal/pancreatic hormone concentrations in the portal venous system of nine patients with organic hyperinsulinism.
    Glaser B; Valtysson G; Fajans SS; Vinik AI; Cho K; Thompson N
    Metabolism; 1981 Oct; 30(10):1001-10. PubMed ID: 6116152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine tumors of the pancreas: clinical, chemical and morphological findings.
    Creutzfeldt W
    Monogr Pathol; 1980; 21():208-30. PubMed ID: 6111748
    [No Abstract]   [Full Text] [Related]  

  • 6. Proinsulin-like component of circulating insulin in the basal state and in patients and hamsters with islet cell tumors.
    Gorden P; Sherman B; Roth J
    J Clin Invest; 1971 Oct; 50(10):2113-22. PubMed ID: 4330005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the source of hyperinsulinism: percutaneous transhepatic portal and pancreatic vein catheterization with hormone assay.
    Cho KJ; Vinik AI; Thompson NW; Shields JJ; Porter DJ; Brady TM; Cadavid G; Fajans SS
    AJR Am J Roentgenol; 1982 Aug; 139(2):237-45. PubMed ID: 6283872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients.
    Klöppel G; Willemer S; Stamm B; Häcki WH; Heitz PU
    Cancer; 1986 May; 57(9):1824-32. PubMed ID: 2420439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and proinsulin metabolism in an unusual case of insulinoma.
    Kreines K; Starr JI; Mako ME
    Ohio State Med J; 1976 Dec; 72(12):704, 707-9. PubMed ID: 186741
    [No Abstract]   [Full Text] [Related]  

  • 10. Separate pancreatic gastrin cell and beta-cell adenomas: report of a patient with multiple endocrine adenomatosis type 1.
    Peurifoy JT; Gomez LG; Thompson JC
    Arch Surg; 1979 Aug; 114(8):956-8. PubMed ID: 37817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation during storage of high molecular weight immunoreactive insulin (HWIRI) and proinsulin (PLC) in extracts of Benign insulinomas and adjacent pancreatic tissue.
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    Horm Metab Res; 1981 Sep; 13(9):528-9. PubMed ID: 6271661
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of multiple endocrine neoplasia, type 1, with parathyroid adenoma, multinodular adrenal cortical hyperplasia, islet cell tumor and hyperplasia of thyroid with concomitant hypersecretion of gastrin and total glucagon-like immunoreactivity].
    Shigematsu S; Shimoyama N; Sato Y; Horita M; Oribe Y; Ono J; Takaki R; Ishimatsu T; Kodama M; Iwashita K
    Nihon Naika Gakkai Zasshi; 1989 Mar; 78(3):357-62. PubMed ID: 2567324
    [No Abstract]   [Full Text] [Related]  

  • 13. A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience.
    Skogseid B; Oberg K; Benson L; Lindgren PG; Lörelius LE; Lundquist G; Wide L; Wilander E
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1233-40. PubMed ID: 2883195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of secretin on the normal and pathological beta-cell.
    Glaser B; Shapiro B; Glowniak J; Fajans SS; Vinik AI
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1138-43. PubMed ID: 2836469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nesidioblastosis and endocrine hyperplasia of the pancreas: a secondary phenomenon.
    Goudswaard WB; Houthoff HJ; Koudstaal J; Zwierstra RP
    Hum Pathol; 1986 Jan; 17(1):46-54. PubMed ID: 2867969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression and stimulation mechanisms controlling glucagon secretion in a case of islet-cell tumor producing glucagon, insulin, and gastrin.
    Tiengo A; Fedele D; Marchiori E; Nosadini R; Muggeo M
    Diabetes; 1976 May; 25(5):408-12. PubMed ID: 5326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis.
    Vance JE; Stoll RW; Kitabchi AE; Buchanan KD; Hollander D; Williams RH
    Am J Med; 1972 Feb; 52(2):211-27. PubMed ID: 4400504
    [No Abstract]   [Full Text] [Related]  

  • 19. High-molecular IRI (big, big insulin) in islet cell adenoma.
    Melani F; Beischer W; Keller L; Pfeiffer EF
    Horm Metab Res; 1976; Suppl 6():63-6. PubMed ID: 179931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome.
    Anlauf M; Schlenger R; Perren A; Bauersfeld J; Koch CA; Dralle H; Raffel A; Knoefel WT; Weihe E; Ruszniewski P; Couvelard A; Komminoth P; Heitz PU; Klöppel G
    Am J Surg Pathol; 2006 May; 30(5):560-74. PubMed ID: 16699310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.